Xu, Y., Li, D., Wang, N., Ge, B., Meng, C., Zhao, M., . . . Ye, H. miR-182 promoter hypermethylation predicts the better outcome of AML patients treated with AZA + VEN in a real-world setting. BMC.
Chicago Style (17th ed.) CitationXu, Yilan, et al. MiR-182 Promoter Hypermethylation Predicts the Better Outcome of AML Patients Treated with AZA + VEN in a Real-world Setting. BMC.
MLA (9th ed.) CitationXu, Yilan, et al. MiR-182 Promoter Hypermethylation Predicts the Better Outcome of AML Patients Treated with AZA + VEN in a Real-world Setting. BMC.
Warning: These citations may not always be 100% accurate.